Global Temperature-Controlled Packaging for Pharmaceutical Market Overview
The global temperature-controlled packaging for pharmaceutical market size is bound to display a stupendous CAGR of 9.48% over the forecast period (2020-2027), according to the latest report by Market Research Future (MRFR). Temperature-controlled solutions are essential in maintaining blood or vaccines. Cold chain solutions are used in this regard for the pharmaceutical industry to cater to the growing demand among patients and rise of lifestyle diseases. The packaging solutions are designed to maintain temperature conditions during the supply chain.
The market is driven by strict regulations to enhance distribution methods of pharmaceutical goods. Research and development programs for enhancing packaging process can encourage market growth. Temperature-controlled drugs and vaccines are shipped in adherence to electromechanical or electronic temperatures with supportive logs documenting its proper storage. Development of new drugs and therapies can spur the demand of cold chain logistics.
Get Free Sample PDF Brochure:
The COVID-19 pandemic has created a lucrative pocket for temperature-controlled packaging solution developers in the pharmaceutical industry. Guidelines outlined by health organizations for preservation of vaccines and drugs has led to development of containers and shippers capable of maintaining the vaccine’s integrity in spite of the container being exposed to ambient temperatures. Dry ice has been utilized for maintaining the thermal temperature of the sensitive vaccines.
Temperature-controlled packaging containers are being developed by keeping the sustainability factor in mind. They are being designed to limit its carbon dioxide emissions to adhere to quality standards and reduce the risks while delivering defective products. Logistics companies are integrating digital technologies for monitoring and tracking their products. For instance, Softbox has partnered with Pfizer in supply and distribution of COVID-19 vaccines with the help of a reusable ultra-low temperature insulated shipper.
By product, the temperature-controlled packaging for pharmaceutical market has been divided into insulated shippers and insulated containers. The insulated shippers segment accounted for more than 62% market share. It stood at a valuation of USD 3,172.3 Mn and is projected to display a CAGR of 9.26% during the assessment period. This is due to rising investments in insulated packaging solutions. They offer effective packaging solutions for temperature sensitive and time-critical products. Insulated shippers are lightweight containers used in shipping of sensitive products. Development of reusable insulated shippers for distribution of low-temperature vaccines is likely to bolster segment demand.
Types of temperature-controlled packaging have been bifurcated into active systems and passive systems. The active systems segment controls the major share of the temperature-controlled packaging for pharmaceutical market. It is expected to remain highly attractive over the next couple of years. It is projected to surpass a market valuation of USD 5,000 Mn over the forecast period. Active systems are containers with temperature control systems which function on electricity. They are secure and assist with quick loading and unloading.
By temperature range, the market has been segmented into more than 20°C, Up to 10°C, and 10°C to 20°C. The up to 10°C segment is projected to exhibit a CAGR of 9.93% during the forecast period. It accounted for 48.20% market share in 2017. This is due to increasing usage of packaging solutions with temperature range of up to 10°C in high-risk products such as blood products, vaccines, insulins, and other protein-dense solutions.
On the basis of payload capacity, the market has been segmented into more than 150 L, 40-150 L, up to 10 L, 10-20 L, and 20-40 L. The up to 10 L segment currently accounts for the largest market share. It is expected to touch a market valuation of over USD 2,600 Mn over the forecast period.
By type of use, the market has been bifurcated into single use and reusable. The single-use segment is leading the market due to its disposable nature. It accounted for more than two-third of the market share in 2017. But the reusable segment is touted to deliver a sharp growth rate over the forecast period owing to sustainable measures taken by pharmaceutical packaging experts.
End-use industries of the market are pharmaceutical and clinical trial. The former segment will deliver a higher performance than the latter throughout the forecast period. In 2017, the pharmaceutical segment can exceed a value of USD 4,000 Mn. It can perform well owing to supply of drugs and blood to patients at hospitals and critical care centers.
In North America, the temperature-controlled packaging for pharmaceutical product market is observed to hold great potential. Factors that are responsible for the rise of the market in the region are stringent safety policies of pharmaceutical products. The US and Canada can rise at a high pace across the review period.
In Europe, the emerging temperature controlled packaging for pharmaceutical products market. The introduction of effective goods distribution practices can underline the rise of the market across the review period. The development in novel packaging solutions can cause Europe market to thrive at 9.42% CAGR in the forecast period.
In Asia Pacific, the temperature controlled packaging for pharmaceutical products market holds several growth prospects. The high investment in R&D rise in pharmaceutical spending by government of different countries of the region can support the expansion of APAC market.
Browse In-depth Market Research Report (170 pages) on Temperature-Controlled Packaging for Pharmaceutical
The temperature-controlled packaging for pharmaceutical market is very competitive and marked by expansions and alliances.
Key players involved in the market are va-Q-tec AG, Pelican Bio Thermal, Storopack Hans Reichenecker GmbH, Cold Chain Technologies, Envirotainer AB, Sofrigam, KUEHNE + NAGEL INC., DHL International GmbH, United Parcel Service of America, Inc. (UPS), DB Schenker, Sonoco ThermoSafe, and Softbox Systems Limited. Sonoco ThermoSafe is dominating the market with 5.2% market share. This is due to its large product portfolio of protective packaging, insulated slippers, and durable insulated containers. It is focusing its efforts on expansions and product developments for gaining customers. On the other hand, Storopack Hans Reichenecker GmbH has 3.8% market share with customized packaging solutions coupled with cushioning to deter any impact during road transport.
American Airlines Cargo has partnered with CSafe Global and CargoSense for providing temperature-controlled packaging solutions to clients. Its successful trials have led to the company expanding its facilities to cities of Pittsburgh, Memphis, and Cincinnati.
Retention of Vaccine Integrity to Drive Demand in Global Temperature-controlled Packaging for Pharmaceutical Market
The global temperature-controlled packaging for pharmaceutical market is set to experience massive demand owing to heavy reliance on medicines and vaccines. The COVID-19 pandemic has boosted the market demand significantly owing to demand for temperature-controlled solutions. Imports and exports of vital drugs coupled with utilization of cold chain logistics can boost market growth.
Browse Related Reports:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future®
99 Hudson Street,5Th Floor
New York, New York 10013
United States of America
+1 628 258 0071(US)
+44 2035 002 764(UK)